We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Dr. Reddy’s Mexico API Site Gets Warning for GMP Issues
Dr. Reddy’s Mexico API Site Gets Warning for GMP Issues
July 5, 2011
The FDA has warned a Dr. Reddy’s active pharmaceutical ingredient (API) manufacturing site in Mexico for failures related to its cleaning validation and analytical methods validation.